KORU Medical Systems Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名49/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價5.65。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。
KORU Medical Systems Inc評分
相關信息
行業排名
49 / 207
全市場排名
150 / 4563
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
5
分析師
買入
評級
5.650
目標均價
-1.40%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
KORU Medical Systems Inc亮點
亮點風險
KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
公司代碼KRMD
公司KORU Medical Systems Inc
CEOTharby (Linda M)
網址https://www.korumedical.com/
常見問題
KORU Medical Systems Inc(KRMD)的當前股價是多少?
KORU Medical Systems Inc(KRMD)的當前股價是 6.230。
KORU Medical Systems Inc 的股票代碼是什麼?
KORU Medical Systems Inc的股票代碼是KRMD。
KORU Medical Systems Inc股票的52週最高點是多少?
KORU Medical Systems Inc股票的52週最高點是6.608。
KORU Medical Systems Inc股票的52週最低點是多少?
KORU Medical Systems Inc股票的52週最低點是1.860。
KORU Medical Systems Inc的市值是多少?
KORU Medical Systems Inc的市值是288.41M。
KORU Medical Systems Inc的淨利潤是多少?
KORU Medical Systems Inc的淨利潤為-6.07M。
現在KORU Medical Systems Inc(KRMD)的股票是買入、持有還是賣出?
根據分析師評級,KORU Medical Systems Inc(KRMD)的總體評級為買入,目標價格為5.650。
KORU Medical Systems Inc(KRMD)股票的每股收益(EPS TTM)是多少
KORU Medical Systems Inc(KRMD)股票的每股收益(EPS TTM)是-0.081。